Key Highlights

  • SANUWAVE Health, Inc. (NASDAQ:SNWV) traded at USD 2.84, down 50.44% in trading on November 5, 2026, per published market data, on thin Volume of about 214,000 shares.
  • Second quarter 2026 Revenue was USD 9.7 million, down 3% from USD 10.1 million, and gross Margin slipped to 76.2% from 78.1% in the prior year period.
  • On August 6, 2026 the company withdrew its 2026 guidance, previously a USD 51 million to USD 55 million revenue view, pending the final CMS rule expected in the fourth quarter.
  • First quarter 2026 revenue had risen 3.1% to USD 9.6 million, and trailing twelve month revenue is about USD 44 million, per published market data.

Guidance Withdrawn Ahead of a Medicare Decision

The most recent major update for SANUWAVE Health, Inc. (NASDAQ:SNWV) came on August 6, 2026, when it reported second quarter results and withdrew its 2026 guidance, saying it would reassess after the final Centers for Medicare and Medicaid Services rule expected in the fourth quarter of 2026. Revenue was USD 9.7 million, down 3% year over year, and gross margin fell to 76.2% from 78.1%. A preliminary figure on July 13, 2026 had put revenue at USD 9.6 million to USD 9.8 million, above a revised June range of USD 8.5 million to USD 9.5 million. The stock then fell 50.44% in trading on November 5, 2026.

What Management Said About the Business

On the second quarter call, management reported record applicator sales but a sharp drop in system sales, citing used-device Market Saturation and industry disruption from Medicare reimbursement cuts. The company release pointed to Medicare reimbursement developments and a 2027 CMS proposed rule for code 97610. Applicators are consumables, which tend to produce steadier revenue than Capital systems, so a shift in mix can support recurring sales while hurting headline growth. Published market data shows trailing twelve month revenue of about USD 44 million, while published per-share Earnings figures are not used here because they cannot be reconciled with reported operating results. With guidance still withdrawn, forward revenue is unquantified by the company, which widens the range of outcomes investors must price.

Thin Liquidity, Reversal Risk and Next Dates

At a stock price below USD 3 and a Market Value of roughly USD 40 million to USD 50 million, a small number of trades can move the price, spreads can be wide and quoted moves can reverse, so the decline should not be read as a trend. The main risks are the final CMS rule, falling system sales, margin pressure and funding needs if growth stalls. Third quarter results are listed on published calendars for around November 6, 2026, which has not been confirmed by the company here. Investors will look for the fourth quarter CMS outcome and any reinstated outlook.

Where Things Stand

SANUWAVE Health, Inc. (NASDAQ:SNWV) lost about half its quoted value because the shares are small, thinly traded and exposed to an uncertain Medicare reimbursement decision, with guidance already withdrawn in August. Falling system sales and a lower gross margin gave holders little fundamental cushion. The move is quoted intraday and may not persist. The next markers are third quarter results, which published calendars place around November 6, 2026, and the final CMS rule expected in the fourth quarter of 2026.